• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV感染患者微生物易位的一般问题。

General issues on microbial translocation in HIV-infected patients.

作者信息

Novati S, Sacchi P, Cima S, Zuccaro V, Columpsi P, Pagani L, Filice G, Bruno R

机构信息

Department of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

出版信息

Eur Rev Med Pharmacol Sci. 2015;19(5):866-78.

PMID:25807441
Abstract

The lumen of the gastrointestinal tract is home to an enormous quantity of different bacterial species that thrive in an often symbiotic relationship with the host. It is the principal source of microbial products because of its massive bacterial load. Injury to the immune component of the gastrointestinal mucosal surface, along with damage to the intestinal epithelial microenvironment with its antimicrobial functions, may affect systemic immune activation during the chronic phase of HIV infection through the increased translocation of luminal microbial products. Moreover, microbial translocation, which is defined as "the passage of both viable and nonviable microbes and microbial products such as endotoxin across anatomically intact intestinal barrier", may be a fundamental mechanism through which HIV accelerates progression of chronic viral hepatitis. Improvements in the tools available to microbiota research, and especially advancement of our knowledge in this area may help us in controlling the evolution of HIV disease, although population complexity and diversity between individuals make this challenging.

摘要

胃肠道管腔是大量不同细菌物种的家园,这些细菌通常与宿主形成共生关系并茁壮成长。由于其大量的细菌负荷,它是微生物产物的主要来源。胃肠道黏膜表面免疫成分的损伤,以及具有抗菌功能的肠道上皮微环境的破坏,可能会通过管腔微生物产物易位增加,在HIV感染的慢性期影响全身免疫激活。此外,微生物易位被定义为“活的和非活的微生物以及诸如内毒素等微生物产物穿过解剖结构完整的肠道屏障”,这可能是HIV加速慢性病毒性肝炎进展的一个基本机制。尽管个体之间的人群复杂性和多样性使这具有挑战性,但微生物群研究可用工具的改进,尤其是我们在这一领域知识的进步,可能有助于我们控制HIV疾病的发展。

相似文献

1
General issues on microbial translocation in HIV-infected patients.HIV感染患者微生物易位的一般问题。
Eur Rev Med Pharmacol Sci. 2015;19(5):866-78.
2
Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection.肠道屏障结构、黏膜免疫与肠道微生物群在HIV感染的发病机制及治疗中的作用
AIDS Res Ther. 2016 Apr 11;13:19. doi: 10.1186/s12981-016-0103-1. eCollection 2016.
3
Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.人类免疫缺陷病毒与丙型肝炎病毒合并感染患者的肠道上皮屏障功能障碍:对固有免疫和获得性免疫的影响
World J Gastroenterol. 2016 Jan 28;22(4):1433-48. doi: 10.3748/wjg.v22.i4.1433.
4
Sequencing of bacterial microflora in peripheral blood: our experience with HIV-infected patients.外周血中细菌微生物群的测序:我们对HIV感染患者的经验。
J Vis Exp. 2011 Jun 11(52):2830. doi: 10.3791/2830.
5
HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.HIV 与肠道微生物群,狼狈为奸:打破恶性循环,发掘新的治疗靶点。
J Immunol Res. 2015;2015:614127. doi: 10.1155/2015/614127. Epub 2015 Feb 22.
6
Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.肠道黏膜屏障功能障碍、微生物群失调及其在HIV-1疾病进展中的作用。
J Infect Dis. 2016 Oct 1;214 Suppl 2(Suppl 2):S58-66. doi: 10.1093/infdis/jiw258.
7
Microbiota-stimulated immune mechanisms to maintain gut homeostasis.微生物群刺激免疫机制以维持肠道内稳态。
Curr Opin Immunol. 2010 Aug;22(4):455-60. doi: 10.1016/j.coi.2010.06.008. Epub 2010 Jul 23.
8
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation.HIV相关免疫激活中的微生物易位与微生物群失调
Curr Opin HIV AIDS. 2016 Mar;11(2):182-90. doi: 10.1097/COH.0000000000000234.
9
Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function?HIV感染中的黏膜免疫:如何恢复胃肠道相关淋巴组织功能?
Curr Opin Infect Dis. 2014 Jun;27(3):275-81. doi: 10.1097/QCO.0000000000000059.
10
Microbial translocation, immune activation, and HIV disease.微生物易位、免疫激活与 HIV 疾病。
Trends Microbiol. 2013 Jan;21(1):6-13. doi: 10.1016/j.tim.2012.09.001. Epub 2012 Oct 11.

引用本文的文献

1
Effect of Opioid Use on Immune Activation and HIV Persistence on ART.阿片类药物使用对 ART 治疗中免疫激活和 HIV 持续存在的影响。
J Neuroimmune Pharmacol. 2020 Dec;15(4):643-657. doi: 10.1007/s11481-020-09959-y. Epub 2020 Sep 25.
2
The Possible Role of Gut Microbiota and Microbial Translocation Profiling During Chemo-Free Treatment of Lymphoid Malignancies.在淋巴恶性肿瘤的无化疗治疗中,肠道微生物群和微生物易位分析可能发挥的作用。
Int J Mol Sci. 2019 Apr 9;20(7):1748. doi: 10.3390/ijms20071748.
3
MicroRNA expression profiling of intestinal mucosa tissue predicts multiple crucial regulatory molecules and signaling pathways for gut barrier dysfunction of AIDS patients.
肠道黏膜组织 microRNA 表达谱预测艾滋病患者肠道屏障功能障碍的多个关键调控分子和信号通路。
Mol Med Rep. 2017 Dec;16(6):8854-8862. doi: 10.3892/mmr.2017.7722. Epub 2017 Oct 4.
4
Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.严重非艾滋病相关事件:HIV感染中免疫激活与慢性炎症的治疗靶点
Drugs. 2016 Apr;76(5):533-49. doi: 10.1007/s40265-016-0546-7.